tetrandrine has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, L; Chu, Y; Dai, Y; Guo, Y; Liu, X; Wei, Z; Xia, Y; Yun, X; Zhang, Y; Zhu, Y | 1 |
| Cheng, LN; Gan, HT; Huang, XL; Shi, W; Xiang, JY; Zhang, DK | 1 |
2 other study(ies) available for tetrandrine and Colitis
| Article | Year |
|---|---|
Tetrandrine attenuates intestinal epithelial barrier defects caused by colitis through promoting the expression of Occludin via the AhR-miR-429 pathway.
Topics: Animals; Benzylisoquinolines; Calcium Channel Blockers; Colitis; Dextran Sulfate; Female; Gene Expression Regulation; Humans; Intestinal Diseases; Intestinal Mucosa; Mice; Mice, Inbred C57BL; MicroRNAs; Occludin; Permeability; Receptors, Aryl Hydrocarbon | 2021 |
Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -kappaB activation.
Topics: Animals; Benzylisoquinolines; Colitis; Dextran Sulfate; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Immunosuppressive Agents; Interleukin-1beta; Mice; Mice, Inbred BALB C; NF-kappa B; Peroxidase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 2009 |